why choose us

First received: February 07, 2023

Clinical Trial: Phase 3 Safety Study for the Treatment of Presbyopia Subjects

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Presbyopia

Study Type: INTERVENTIONAL


Official Title: Safety Study: A Multi-Center, Double-Masked Phase 3 Safety Study Evaluation of the Long-Term Safety of LNZ101 in Presbyopic Subjects

Brief Summary: Safety Study of the Long-Term Safety of LNZ101 in Presbyopic Subjects

Read more